ASSESSMENT OF THE EFFECTIVENESS OF THE CLINICAL AND PHARMACOECONOMIC ASPECTS OF TOPAMAX IN PATIENTS WITH EPILEPSY. ReFocus 2023, 2 (5), 198-202. https://doi.org/10.66073/researchfocus.v2i5.247.